S&P 500: Any Juice Left?

Lior Alkalay - INO.com Contributor


The S&P 500 (CME:SP500) closed for the week at 2,472.10, after hitting an all-time record, after gaining 10.5% year-to-date. The S&P’s forward Price-to-Earnings ratio, a key ratio for investors, is 17.8 above the 10-year average of 14. And this brings up the inevitable pondering; is there any juice left in the S&P 500?

In searching for an answer, the intuitive starting point might be the S&P’s valuation. We’ve already pointed out that the S&P 500 is trading at a high valuation compared to its 10-year average. Furthermore, according to Factset research, earnings for the 500 companies which comprise the S&P 500 are expected to rise by 9.3% as compared to 9.26% in 2016. Now, while that is a solid figure, it also suggests earnings growth is not accelerating and may even suggest the acceleration in earnings growth is over. And if earnings growth is likely to decelerate in the coming years it cannot account for the S&P500’s 17.8 PE ratio. So, there’s no valid reason why the S&P’s valuation would be the catalyst for another surge. Why not? Simply because it's too high. In fact, the real catalyst isn’t within the S&P500 or even within the stock market; instead, the real reason lies within the Bond market. Continue reading "S&P 500: Any Juice Left?"

Markets Dragged Lower By Amazon

Hello traders everywhere. Amazon.com Inc (NASDAQ:AMZN) shares fell a little over 2% after it reported a 77% drop in profit as its rapid and costly expansion into new shopping categories and countries shows no sign of slowing. Amazon is the worst performer on the NASDAQ and the second biggest drag on the S&P 500 today, pulling down both indexes today.

MarketClub's Mid-day Market Report

In economic news, U.S. economic growth for the second quarter came in-line with expectations, the Commerce Department said Friday. The U.S. economy grew at an annualized rate of 2.%, matching estimates.

Key levels to watch next week: Continue reading "Markets Dragged Lower By Amazon"

Cannabis Cancer Stock Up 207% In 2017

Analysis originally distributed on July 19, 2017 By: Michael Vodicka of Cannabis Stock Trades

Cannabis is a proven treatment for cancer patients struggling with the side effects of chemotherapy such as nausea and loss of appetite.

But now, pre clinical research is showing that cannabis could actually be a cancer killer.

A group of scientists recently reported that THC and CBD slowed the growth and even killed certain cancer cells – including breast, brain and liver cancer – when grown in a lab.

Animal studies also suggest that cannabis could be a cancer killer.

A study conducted by Complutense University, one of the oldest and largest universities in Europe located in Madrid, showed that an injection of a synthetic THC eliminated malignant brain tumors in 1/3 of the rats studied while extending the life of another 1/3. Continue reading "Cannabis Cancer Stock Up 207% In 2017"

The Fed, Facebook and Record Highs

Hello traders everywhere. Strong quarterly earnings have propelled the DOW, S&P 500 and NASDAQ to record highs today. Just to give you an idea of how great earnings season has been so far. 34% of the S&P 500 components have reported as of today, and 78% of them have beaten expectations on the bottom line, and 73% have topped on sales, according to data from The Earnings Scout. I'd say that's pretty impressive.

MarketClub's Mid-day Market Report

The Federal Reserve will release its FOMC meeting minutes today at 2 pm, and it is widely expected to keep monetary policy unchanged, but investors will look for clues about the central bank's next move.

Facebook Inc (NASDAQ:FB) is set to report earnings after the close today. Wall Street expects Facebook to report second-quarter profits of $1.13 per share, based on the average estimate of 35 analysts who rate its stock. That's up from 97 cents per share a year earlier with revenue rising to $9.2 billion, a jump of 43% year-over-year. According to most estimates.

Key levels to watch next week: Continue reading "The Fed, Facebook and Record Highs"

Upcoming Facebook Earnings - A Nonevent Long-Term

Noah Kiedrowski - INO.com Contributor - Biotech


Upcoming Earnings

Facebook Inc. (NASDAQ:FB) is due to announce earnings on July 26th after the market closes. Facebook tends to be volatile after earnings are announced and typically pop to the upside as Facebook’s earnings have continued to post robust growth. Back on June 2nd, 2017, I authored an article “Facebook Will Hit $175 By Year End” and with five more months to go before the end of the year, I think Facebook has a good chance of breaking through this number. Facebook has been on an uptrend heading into earnings and currently sits at $160 per share and while the stock is up 39% YTD. These numbers may seem staggering, and some would state that buying at these levels would be cashing the stock. Normally I would agree with this approach. However, I think Facebook is an exception to this situation. Even at these levels and YTD appreciation, factoring in Facebook’s projected growth with tech comparators such as Alphabet Inc. (NASDAQ:GOOG), Netflix Inc. (NASDAQ:NFLX) and Amazon.com (NASDAQ:AMZN), collectively known as the FANG stocks, Facebook is superior with a lower risk profile. Facebook’s projected growth is greater than Google’s and just shy of Amazon’s yet has a P/E ratio that’s lower than Google’s and a fraction of Amazon’s and Netflix’s. Regardless of the upcoming earnings announcement, this will be an immaterial event to the long term narrative for Facebook investors. I feel that Facebook represents value even after this massive run YTD and continue my long thesis. Continue reading "Upcoming Facebook Earnings - A Nonevent Long-Term"